Literature DB >> 2678668

T-zone histiocytes and recurrence of papillary urothelial bladder carcinoma.

A Lopez-Beltran1, C Morales, C Reymundo, M Toro.   

Abstract

We have studied the histologic distribution and prognostic significance of T-zone histiocytes (TZH) in 89 papillary urothelial bladder carcinomas (PUC), 3 cases of nonspecific cystitis (NC) and 4 cases of follicular cystitis (FC) by immunohistochemical determination of S-100 protein. Nineteen (21.37%) of the PUC cases have been found to have TZH S-100-positive with a variable density intratumor, along the papillary axis, or in the lymphoid aggregates of the vesical wall. All four FC cases were also TZH-positive, with a distribution and density similar to those of follicular dendritic cells of lymph nodes, although none of the 3 NC cases presented TZH. The recurrence-free period was significantly (p less than 0.05) longer in TZH-positive patients.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2678668     DOI: 10.1159/000281505

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  4 in total

1.  The prognostic value of basement membrane morphology, tumour histology and morphometry in superficial bladder cancer.

Authors:  P K Lipponen
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

Review 2.  Focus on TILs: Prognostic significance of tumor infiltrating lymphocytes in human bladder cancer.

Authors:  Chrysoula I Liakou; Sowmita Narayanan; Derek Ng Tang; Christopher J Logothetis; Padmanee Sharma
Journal:  Cancer Immun       Date:  2007-06-26

3.  Lymphoepithelioma-like carcinoma of the bladder: three cases with clinicopathological and p53 protein expression study.

Authors:  Francisco Miguel Izquierdo-García; Fructuoso García-Díez; Isabel Fernández; Alberto Pérez-Rosado; Anabel Sáez; Dimas Suárez-Vilela; Rafael Guerreiro-González; Manuel Benéitez-Alvarez
Journal:  Virchows Arch       Date:  2004-04-06       Impact factor: 4.064

4.  An essential role for decorin in bladder cancer invasiveness.

Authors:  Mohamed El Behi; Sophie Krumeich; Catalina Lodillinsky; Aurélie Kamoun; Lorenzo Tibaldi; Gaël Sugano; Aurélien De Reynies; Elodie Chapeaublanc; Agnès Laplanche; Thierry Lebret; Yves Allory; François Radvanyi; Olivier Lantz; Ana María Eiján; Isabelle Bernard-Pierrot; Clotilde Théry
Journal:  EMBO Mol Med       Date:  2013-10-20       Impact factor: 12.137

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.